Euromedic International is a pan-European medical service provider.
In September 2008, Montagu Private Equity successfully completed its co-investment in the leveraged buyout of Euromedic. Montagu invested alongside Merrill Lynch Global Private Equity ("MLGPE"), Ares Life Sciences and the management of the Company. In July 2012, Montagu together with Ares Life Sciences bought out the stake held by MLGPE and took control over the Company.
Founded in 1991, Euromedic International is the largest pan-European provider of healthcare services, focused on advanced diagnostic imaging and cancer care. The Company operates 141 medical centres in 14 countries. Central and Eastern Europe accounts for c.60% of the business (key countries include Poland, Hungary, Czech Republic, Romania and Turkey), with the remaining 40% generated in Western Europe (mainly Switzerland and Northern Italy). Each year, Euromedic treats over 4 million patients of which more than 12,000 are served in Euromedic’s cancer treatment centres. The Company employs close to 3,000 people of which over 1,700 are highly qualified medical professionals including over 800 doctors.
Since the MBO in 2008, Euromedic has grown both organically and through add-on acquisitions improving its profitability and cash generation as a result of inherent economies of scale and business optimization. The business expanded into new CEE markets, developed cancer care capabilities and increased its total centre base by 80%, while a number of non-core assets (clinical laboratories in the Czech Republic and the dialysis division) were sold.